These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28318396)

  • 41. Durable coexistence of donor and recipient strains after fecal microbiota transplantation.
    Li SS; Zhu A; Benes V; Costea PI; Hercog R; Hildebrand F; Huerta-Cepas J; Nieuwdorp M; Salojärvi J; Voigt AY; Zeller G; Sunagawa S; de Vos WM; Bork P
    Science; 2016 Apr; 352(6285):586-9. PubMed ID: 27126044
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How to Manipulate the Microbiota: Fecal Microbiota Transplantation.
    Fuentes S; de Vos WM
    Adv Exp Med Biol; 2016; 902():143-53. PubMed ID: 27161356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized clinical trial to evaluate the effect of fecal microbiota transplant for initial Clostridium difficile infection in intestinal microbiome.
    Camacho-Ortiz A; Gutiérrez-Delgado EM; Garcia-Mazcorro JF; Mendoza-Olazarán S; Martínez-Meléndez A; Palau-Davila L; Baines SD; Maldonado-Garza H; Garza-González E
    PLoS One; 2017; 12(12):e0189768. PubMed ID: 29261736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Moving fecal microbiota transplantation into the mainstream.
    Orenstein R; Griesbach CL; DiBaise JK
    Nutr Clin Pract; 2013 Oct; 28(5):589-98. PubMed ID: 23979974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Fecal microbiota transplantation, a novel therapy for recurrent Clostridium difficile infection].
    Terveer EM; van Beurden YH; Kuijper EJ; Keller JJ
    Ned Tijdschr Tandheelkd; 2016 Sep; 123(9):406-9. PubMed ID: 27643493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stability and efficacy of frozen and lyophilized fecal microbiota transplant (FMT) product in a mouse model of Clostridium difficile infection (CDI).
    Jiang ZD; Alexander A; Ke S; Valilis EM; Hu S; Li B; DuPont HL
    Anaerobe; 2017 Dec; 48():110-114. PubMed ID: 28801119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The microbiome as a source of new enterprises and job creation: Considering clinical faecal and synthetic microbiome transplants and therapeutic regulation.
    van der Lelie D; Taghavi S; Henry C; Gilbert JA
    Microb Biotechnol; 2017 Jan; 10(1):4-5. PubMed ID: 28052560
    [No Abstract]   [Full Text] [Related]  

  • 48. [Current research progress and thinking of fecal microbiota transplantation for the treatment of gastrointestinal disorders].
    Li N; Tian H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1104-1108. PubMed ID: 29130220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Five years of fecal microbiota transplantation - an update of the Israeli experience.
    Greenberg SA; Youngster I; Cohen NA; Livovsky DM; Strahilevitz J; Israeli E; Melzer E; Paz K; Fliss-Isakov N; Maharshak N
    World J Gastroenterol; 2018 Dec; 24(47):5403-5414. PubMed ID: 30598584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fecal microbiota transplantation for recurrent clostridium difficile infection in children.
    Chen B; Avinashi V; Dobson S
    J Infect; 2017 Jun; 74 Suppl 1():S120-S127. PubMed ID: 28646951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis.
    Wei Y; Yang J; Wang J; Yang Y; Huang J; Gong H; Cui H; Chen D
    Crit Care; 2016 Oct; 20(1):332. PubMed ID: 27751177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alternatives to fecal transplants near approval.
    Servick K
    Science; 2022 Jan; 375(6579):368-369. PubMed ID: 35084969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection.
    Jalanka J; Mattila E; Jouhten H; Hartman J; de Vos WM; Arkkila P; Satokari R
    BMC Med; 2016 Oct; 14(1):155. PubMed ID: 27724956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Scaling Safe Access to Fecal Microbiota Transplantation: Past, Present, and Future.
    Panchal P; Budree S; Scheeler A; Medina G; Seng M; Wong WF; Elliott R; Eliott R; Mitchell T; Kassam Z; Allegretti JR; Osman M
    Curr Gastroenterol Rep; 2018 Mar; 20(4):14. PubMed ID: 29594746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases.
    Cammarota G; Pecere S; Ianiro G; Masucci L; Currò D
    Dig Dis; 2016; 34(3):279-85. PubMed ID: 27027524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fecal Microbiota Therapy With a Focus on Clostridium difficile Infection.
    Brandt LJ
    Psychosom Med; 2017 Oct; 79(8):868-873. PubMed ID: 28976455
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease.
    Newman KM; Rank KM; Vaughn BP; Khoruts A
    Gut Microbes; 2017 May; 8(3):303-309. PubMed ID: 28102756
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Fecal microbiota transplantation: review].
    Barbut F; Collignon A; Butel MJ; Bourlioux P
    Ann Pharm Fr; 2015 Jan; 73(1):13-21. PubMed ID: 25577013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fecal microbial transplantation as a therapeutic option in patients colonized with antibiotic resistant organisms.
    Laffin M; Millan B; Madsen KL
    Gut Microbes; 2017 May; 8(3):221-224. PubMed ID: 28059612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases?
    Kump P; Högenauer C
    Dig Dis; 2016; 34 Suppl 1():74-81. PubMed ID: 27548724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.